EgyVet is a government-owned company operating since 2005 in animal health care under the Ministries of Health and Agriculture.
Mission: Improving health and vitality of small and large animals and poultry; preventing zoonotic disease transmission; protecting Egypt's animal and poultry wealth.
Vision: Become a leading veterinary health care company in Egypt, establishing new standards for availability and quality.
Product portfolio: Bacterial Autogenous Vaccines (first unit in Egypt for strain-specific vaccines from local field isolates), Viral Vaccines, Veterinary Drugs, Feed Additives.
Strategic Partnerships: Korveda (poultry & bovine vaccines, Egg-Based Viral Vaccines for Avian Influenza & Newcastle Disease), El Motahida (Vacderm line for pets and equine).
Future Projects: GMP-compliant plant in 6th of October City for inactivated H5N1 avian influenza and egg-based vaccines — capacity up to 800 million doses annually. COVID-19 line establishment & filling project.